Quanta

Quanta is a medical devices company that develops advanced haemodialysis systems for use in the home and clinic. Quanta is focused on the commercialisation and ongoing development of SC+, an innovative cartridge-based haemodialysis system.

SC+ is a high performance, compact haemodialysis system providing clinical efficacy by utilising typical flow rates of traditional in-centre machines.

SC+ supports the entire ‘Continuum of Care’ for dialysis patients, from nurse-assisted treatment through self-care in centre to home haemodialysis. Their system facilitates the seamless transition between treatment modalities providing the best tool to enable flexibility for patients, and treatment options for physicians.

Quanta headquartered in Europe, operates in the Health Care, Medical, Manufacturing, Medical Device, Clinical Trials sector. The company focuses on Health Care and has secured $35.2B in funding across 100 round(s). With a team of 101-250 employees, Quanta is actively contributing to advancements in Health Care. Their latest funding round, Series A - Quanta, raised $14.3M. Discover more about their projects, partnerships, and impact on our platform.